Spero Therapeutics, Inc. (SPRO) Free Cash Flow
Spero Therapeutics, Inc. (SPRO) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2017-12-31 | -$39.14M |
| 2018-12-31 | -$42.06M |
| 2019-12-31 | -$50.33M |
| 2020-12-31 | -$85.87M |
| 2021-12-31 | -$64.35M |
| 2022-12-31 | -$7.73M |
| 2023-12-31 | -$32.99M |
| 2024-12-31 | -$23.44M |
| 2025-12-31 | -$12.62M |
How SPRO compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| RMTI | Rockwell Medical Inc. | -$1.24M |
| NMTC | NeuroOne Medical Technologies Corporation | -$2.92M |
| AXGN | Axogen Inc. | -$4.78M |
| PMCB | PharmaCyte Biotech Inc. | -$5.15M |
| DYAI | Dyadic International Inc. | -$5.70M |
These are five companies in the same sector as SPRO with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Spero Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("SPRO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SPRO | $1.22 | +0.83% | 0.36M |
| 3 | ||||
| 4 | ||||
| 5 |